Belpointe Asset Management’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-90
Closed -$1.85K 2092
2023
Q1
$1.85K Hold
90
﹤0.01% 3323
2022
Q4
$1.93K Buy
+90
New +$1.77K ﹤0.01% 3275

Other funds holding KURE

Belpointe Asset Management's KURE Position: Q2 2023 in Review

Belpointe Asset Management sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q2 2023, closing a stake of 90 shares — an estimated $1.85K sold.

Belpointe Asset Management first reported a position in KURE in Q4 2022 and held it in 2 quarters. The position peaked at $1.93K in Q4 2022. 16 funds tracked by Wall St. Rank hold KURE as of Q2 2023.

  • Belpointe Asset Management reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 90 KraneShares MSCI All China Health Care Index ETF shares in Q2 2023, an estimated $1.85K.
  • Belpointe Asset Management first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's KraneShares MSCI All China Health Care Index ETF position peaked at $1.93K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.